Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting
Balram Bhargava, MD, DMa,
Ran Kornowski, MD, FACCa,
Roxana Mehran, MD, FACCa,
Kenneth M. Kent, MD, PhD, FACCa,
Mun K. Hong, MD, FACCa,
Alexandra J. Lansky, MD, FACCa,
Ron Waksman, MD, FACCa,
Augusto D. Pichard, MD, FACCa,
Lowell F. Satler, MD, FACCa and
Martin B. Leon, MD, FACCa
a Cardiac Catheterization Laboratory, Division of Cardiology, Washington Hospital Center, Washington, DC, USA
View larger version (83K):
[in a new window]
|
Figure 1 A, Before (arrow, left panel) and after (right panel) stenting of the proximal SVG to the right coronary artery (RCA). B, Before (arrow, left panel) and after (right panel) stenting of the distal SVG to the RCA. C, Before (arrows, left panel) and after (right panel) stenting of diffuse proximal disease in the SVG to the left anterior descending coronary artery (LAD). D, Before (arrows, left panel) and after (right panel) stenting of distal disease in the SVG to the LAD, with excellent angiographic results at both treatment sites. All four SVG lesions were in the same patient and treated at the same intervention.
|
|
View larger version (11K):
[in a new window]
|
Figure 2 Actuarial event-free survival curves for any adverse event (death, Q wave MI, PTCA or CABG) for 18 months after single or multiple SVG stenting.
|
|
|
